Top of this page
Skip navigation, go straight to the content
Dr Fildes is an independent director and consultant to the pharmaceutical and biotechnology industries. He is on the Board of ProStrakan Group plc, a European speciality pharmaceutical company and a Non-Executive Director of Piramed Ltd, a UK-based drug discovery and development company. He is also currently a member of the Product Review Board for Ferring Pharmaceuticals and the New Agents Committee for Cancer Research UK. He was a Non-Executive Director of Keryx Biopharmaceuticals Inc and on the Healthcare Advisory Boards for venture capital groups Apax and Merlin Biosciences.
His career in the pharmaceuticals industry was with ICI/Zeneca/AstraZeneca where he held a number of senior R&D leadership roles, latterly as Senior Vice President and Head of Global Development. He was a member of the Board of AstraZeneca Japan, Senior Vice President Pre-Clinical Sciences and Head of Global Development Projects.
Dr Fildes is a Fellow of the Royal Society of Medicine and the Royal Society of Chemistry and in 2001 he was awarded an Honorary Doctor of Science from the University of Bradford.
